0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Research Letter |  ONLINE FIRST
Mehmet Burcu, MS; Julie M. Zito, PhD; Leanne Metcalfe, PhD; et al.
JAMA Psychiatry. Published online June 22, 2016. doi:10.1001/jamapsychiatry.2016.1182

Editorial |  ONLINE FIRST
Gerard Sanacora, MD, PhD
JAMA Psychiatry. Published online June 15, 2016. doi:10.1001/jamapsychiatry.2016.0780

Original Investigation |  ONLINE FIRST
Jorge A. Quiroz, MD, MBA; Paul Tamburri, PharmD; Dennis Deptula, PhD; et al.
JAMA Psychiatry. Published online June 15, 2016. doi:10.1001/jamapsychiatry.2016.0838
Includes: Supplemental Content

Original Investigation |  ONLINE FIRST
M. Katherine Shear, MD; Charles F. Reynolds III, MD; Naomi M. Simon, MD, MSc; et al.
JAMA Psychiatry. Published online June 08, 2016. doi:10.1001/jamapsychiatry.2016.0892
Includes: Supplemental Content

Original Investigation | 
Willem Kuyken, PhD; Fiona C. Warren, PhD; Rod S. Taylor, PhD; et al.
JAMA Psychiatry. 2016;73(6):565-574. doi:10.1001/jamapsychiatry.2016.0076.
Includes: Supplemental Content

Original Investigation | 
Joseph F. Hayes, MSc, MBChB; Alexandra Pitman, PhD; Louise Marston, PhD; et al.
JAMA Psychiatry. 2016;73(6):630-637. doi:10.1001/jamapsychiatry.2016.0432.

Original Investigation |  ONLINE FIRST
Elaine H. Morrato, DrPH, MPH; Elizabeth J. Campagna, MS; Sarah E. Brewer, MPA; et al.
JAMA Psychiatry. Published online May 11, 2016. doi:10.1001/jamapsychiatry.2016.0538
Includes: Supplemental Content

Original Investigation | 
Jon E. Grant, JD, MD, MPH; Samuel R. Chamberlain, MD, PhD; Sarah A. Redden, BA; et al.
JAMA Psychiatry. 2016;73(5):490-496. doi:10.1001/jamapsychiatry.2016.0060.
Includes: Supplemental Content

Original Investigation | 
Eugenia Oviedo-Joekes, PhD; Daphne Guh, MSc; Suzanne Brissette, MD; et al.
JAMA Psychiatry. 2016;73(5):447-455. doi:10.1001/jamapsychiatry.2016.0109.
Includes: CME, Supplemental Content

Viewpoint | 
Carl Elliott, MD, PhD; Matt Lamkin, MA, JD
JAMA Psychiatry. 2016;73(4):317-318. doi:10.1001/jamapsychiatry.2015.3117.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
News From the Food and Drug Administration  | 
Olanzapine Linked With Potentially Fatal Skin Reaction
Rebecca Voelker, MSJ
JAMA
News From the Food and Drug Administration  | 
Antipsychotic Drug May Cause Impulse-Control Problems
Rebecca Voelker, MSJ
JAMA
Original Investigation  | 
Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain
Wayne A. Ray, PhD; Cecilia P. Chung, MD, MPH; Katherine T. Murray, MD; et al.
JAMA Internal Medicine
Original Investigation  | 
Estimation of Potential Savings Through Therapeutic Substitution
Michael E. Johansen, MD, MS; Caroline Richardson, MD